Synthesis and antibacterial activity of substituted oxotriazolylphenyl oxazolidinones

Chemical Biology and Drug Design

Volumn 70, Issue 1, 2007, Pages 65-69

  Liu, Jidong ^a,b   He, Baoyuan ^a   Yu, Aizhen ^a   Zhou, Weicheng ^a  

^a SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY   (China)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

Antibacterial agents; Gram positive bacteria; Linezolid; Multidrug resistance; Oxazolidinone; Oxotriazole

Indexed keywords

5 CHLOROACETAMIDO; 5 DICHLOROACETAMIDO; 5 TRIFLUOROACETAMIDO; ACETAMIDE DERIVATIVE; AGAR; ALKYL GROUP; OXAZOLIDINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); DILUTION; DRUG DESIGN; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH INHIBITION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS ENTERIDIS; STREPTOCOCCUS NONHEMOLYTICUS; STREPTOCOCCUS PNEUMONIA;

ANTI-BACTERIAL AGENTS; MOLECULAR STRUCTURE; OXAZOLIDINONES; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS;

NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 34447334602     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2007.00531.x     Document Type: Article

References (28)

1. Spera R.V. Jr., Farber B.F. (1994) Multidrug-resistant Enterococcus faecium. an untreatable nosocomial pathogen. Drugs 48 : 678 688.
2. Tomasz A. (1994) Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. N Engl J Med 330 : 1247 1251.
3. Fekete T. (1995) Bacterial genetics, antibiotic usage, and public policy: The crucial interplay in emerging resistance. Perspect Biol Med 38 : 363 382.
4. Courvalin P. (1994) Transfer of antibiotic resistance genes between Gram-positive and Gram-negative bacteria. Antimicrob Agents Chemother 38 : 1447 1451.
5. Boyce J.M., Opal S. M., Chow J.W., Zervos M.J., Potter-Bynoe G., Sherman C.B., Romulo R.L., Fortna S., Medeiros A.A. (1994) Outbreak of multidrug-resistant Enterococus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 32 : 1148 1153.
6. Brickner S.J., Hutchinson D.K., Barbachyn M.R., Manninen P.R., Ulanowicz D.A., Garmon S.A., Grega K.C., Hendges S.K., Toops D.S., Ford C.W., Zurenko G.E. (1996) Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant Gram-positive bacterial infections. J Med Chem 39 : 673 679.
7. Eustice D.C., Feldman P.A., Slee A.M. (1988) The mechanism of action of Dup 721, a new antibacterial agent: effects on macromolecular synthesis. Biochem Biophys Res Commun 150 : 965 971.
8. Eustice D.C., Feldman P.A., Zajac I., Slee A.M. (1988) Mechanism of action of Dup 721: inhibition of an early event during initiation of protein synthesis. Antimicrob Agents Chemother 32 : 1218 1222.
9. Johnson A.P., Tysall L., Stockdale M.V., Woodford N., Kaufmann M.E., Warner M., Livermore D.M., Asboth F., Allerberger F.J. (2002) Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit. Eur J Clin Microbial Infect Dis 21 : 751 754.
10. Auckland C., Teare L., Cooke F., Kaufmann M.E., Warner M., Jones G., Bamford K., Ayles H., Johnson A.P. (2002) Linezolid-resistant enterococci: report of the first isolates in the United Kingdom. J Antimicrob Chemother 50 : 743 746.
11. Tsiodras S., Gold H.S., Sakoulas G., Eliopoulos G.M., Wennersten C., Venkataraman L., Moellering R.C., Ferraro M.J. (2001) Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358 : 207 208.
12. Wilson P., Andrews J.A., Charlesworth R., Walesby R., Singer M., Farrell D.J., Robbins M. (2003) Linezolid resistance in clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 51 : 186 188.
13. Park C., Brittelli D.R., Wang C.L.J., Marsh F.D., Gregory W.A., Wuonola M.A., McRipley R.J., Eberly V.S., Slee A.M., Forbes M. (1992) Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 4. Multiply-substituted aryl derivatives. J Med Chem 35 : 1156 1165.
14. Gregory W.A., Brittelli D.R., Wang C.L.J., Kezar H. S. III., Carlson R.K., Park, C., Corless P.F., Miller S.J., Rajagopalan P., Wuonola M.A., McRipley R.J., Eberly V.S., Slee A.M., Forbes M. (1990) Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 2. The ''A'' group. J Med Chem 33 : 2569 2578.
15. Gregory W.A., Brittelli D.R., Wang C.L.J., Wuonola, M.A., McRipley R.J., Eustice D.C., Eberly V.S., Slee A.M., Forbes M., Bartholomew P.T. (1989) Antibacterials. Synthesis and structure-activity studies of 3-aryl-2- oxooxazolidines. 1. The B group. J Med Chem 32 : 1673 1681.
16. Betts M. J., Darbyshire C.J. (1998) WO Patent 9801447.
17. Genin M.J., Allwine D.A., Anderson D.J., Barbachyn M.R., Emmert D.E., Garmon S.A., Graber D.R., Grega K.C., Hester J.B., Hutchinson D.K., Morris J., Reischer R.J., Ford C.W., Zurenko G.E., Hamel J.C., Schaadt R.D., Stapert D., Yagi B.H. (2000) Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious Gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. J Med Chem 43 : 953 970.
18. Betts M.J., Mills, S.D., Roberts, D.A., Swain M.L. (1997) WO Patent 9731917.
19. Ruppelt M., Bartel S., Guarnieri W., Raddatz S., Rosentreter U., Wild H., Endermann R., Kroll H. (1999) DE Patent 19802235.
20. Heeres J., Backx L.J.J., Van Cutsem V. (1984) Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones. J Med Chem 27 : 894 900.
21. Liu J., He B., Yu A., Zhou W. (2007) Synthesis and in vitro evaluation of substituted phenyl-piperazinyl-phenyl oxazolidinones against Gram-positive bacteria. Chem Bio & Drug Des 69 : 265 268.
22. Andrews J.M. (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48 : 5 16.
23. Zhang Z., Zhou W., Yu A. (2004) Synthesis and antibacterial activity of 7-(substituted) aminomethyl quinolones. Bioorg Med Chem Lett 14 : 393 395.
24. Bartel S., Raddatz S., Haerter M., Rosentreter U., Wild H., Endermann R., Kroll H. (2000) DE Patent 19905278.
25. Hester J.B. Jr., Nidy E.G., Perricone S.C., Poel T. (2000) WO Patent 0032599.
26. Tokuyama R., Takahashi Y., Tomita Y., Tsubouchi M., Yoshida T., Iwasaki N., Kado N., Okezaki E., Nagata O. (2001) Structure-activity relationship (SAR) studies on oxazolidinone antibacterial agents. 2. Relationship between lipophilicity and antibacterial activity in 5-thiocarbonyl oxazolidinones. Chem Pharm Bull 49 : 353 360.
27. Tokuyama R., Takahashi Y., Tomita Y., Tsubouchi M., Iwasaki N., Kado N., Okezaki E., Nagata O. (2001) Structure-activity relationship (SAR) studies on oxazolidinone antibacterial agents. 3. Synthesis and evaluation of 5-thiocarbamate oxazolidinones. Chem Pharm Bull 49 : 361 367.
28. clog P Calculation. Organic Chemistry Portal. http://www.organic- chemistry.org/prog/peo/cLogP.html.